Technology
MyoVista® wavECG
StableFollow
01
Recent changes
- HeartSciences Receives FDA 510(k) Clearance for MyoVista® wavECG DeviceHeartSciences Inc. received FDA 510(k) clearance for its MyoVista® wavECG device, allowing it to be used for 12-lead resting ECG in hospitals and healthcare facilities. The clearance does not include an AI-ECG algorithm, and the company plans to evaluate its options for commercialization.StableMarkets1 sources · 1 primary · 7 evidence2026-10-06 20:30